A unique dynamin-related protein is essential for mitochondrial fission in Toxoplasma gondii.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
04 2019
Historique:
received: 29 07 2018
accepted: 10 12 2018
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 18 5 2019
Statut: epublish

Résumé

The single mitochondrion of apicomplexan protozoa is thought to be critical for all stages of the life cycle, and is a validated drug target against these important human and veterinary parasites. In contrast to other eukaryotes, replication of the mitochondrion is tightly linked to the cell cycle. A key step in mitochondrial segregation is the fission event, which in many eukaryotes occurs by the action of dynamins constricting the outer membrane of the mitochondria from the cytosolic face. To date, none of the components of the apicomplexan fission machinery have been identified and validated. We identify here a highly divergent, dynamin-related protein (TgDrpC), conserved in apicomplexans as essential for mitochondrial biogenesis and potentially for fission in Toxoplasma gondii. We show that TgDrpC is found adjacent to the mitochondrion, and is localised both at its periphery and at its basal part, where fission is expected to occur. We demonstrate that depletion or dominant negative expression of TgDrpC results in interconnected mitochondria and ultimately in drastic changes in mitochondrial morphology, as well as in parasite death. Intriguingly, we find that the canonical adaptor TgFis1 is not required for mitochondrial fission. The identification of an Apicomplexa-specific enzyme required for mitochondrial biogenesis and essential for parasite growth highlights parasite adaptation. This work paves the way for future drug development targeting TgDrpC, and for the analysis of additional partners involved in this crucial step of apicomplexan multiplication.

Identifiants

pubmed: 30947298
doi: 10.1371/journal.ppat.1007512
pii: PPATHOGENS-D-18-01501
pmc: PMC6448817
doi:

Substances chimiques

Protozoan Proteins 0
Dynamins EC 3.6.5.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007512

Subventions

Organisme : Medical Research Council
ID : MC_PC_17190
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N003675/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M024156/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Cell Biol. 1993 Aug;122(3):565-78
pubmed: 8335685
Trends Parasitol. 2008 Oct;24(10):468-78
pubmed: 18775675
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252-8
pubmed: 24782522
Mol Biol Cell. 2008 Jun;19(6):2402-12
pubmed: 18353969
Mol Biol Cell. 2000 Apr;11(4):1385-400
pubmed: 10749937
Cell Host Microbe. 2012 Nov 15;12(5):682-92
pubmed: 23159057
PLoS Pathog. 2010 Feb 05;6(2):e1000754
pubmed: 20140195
Elife. 2017 Mar 21;6:
pubmed: 28322189
Trends Parasitol. 2016 Jan;32(1):56-70
pubmed: 26472327
Nature. 2016 Dec 1;540(7631):139-143
pubmed: 27798601
Eur Biophys J. 2011 Jul;40(7):843-56
pubmed: 21533652
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5727-31
pubmed: 11960028
Curr Biol. 2009 Feb 24;19(4):277-86
pubmed: 19217293
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13093-8
pubmed: 25149858
Biochim Biophys Acta. 2006 May-Jun;1763(5-6):510-21
pubmed: 16690143
J Cell Biol. 2000 Oct 16;151(2):367-80
pubmed: 11038183
J Cell Sci. 2006 Aug 1;119(Pt 15):3098-106
pubmed: 16835275
J Biol Chem. 2016 Sep 9;291(37):19335-50
pubmed: 27458014
J Cell Biol. 2000 Oct 16;151(2):F1-4
pubmed: 11038192
Elife. 2015 Aug 25;4:
pubmed: 26305500
J Cell Biol. 2003 Nov 10;163(3):503-10
pubmed: 14597773
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):E1342-51
pubmed: 23530241
J Cell Biol. 2005 Sep 26;170(7):1021-7
pubmed: 16186251
Sci Rep. 2017 Sep 5;7(1):10480
pubmed: 28874689
Int J Biochem Cell Biol. 2009 Oct;41(10):2069-80
pubmed: 19379828
EMBO Rep. 2011 Jun;12(6):565-73
pubmed: 21508961
J Struct Biol. 2000 May;130(1):27-33
pubmed: 10806088
FEMS Microbiol Rev. 2006 Jul;30(4):596-630
pubmed: 16774588
Methods Cell Biol. 1994;45:27-63
pubmed: 7707991
Curr Biol. 2014 Feb 17;24(4):409-14
pubmed: 24485837
J Cell Biol. 1998 Oct 19;143(2):333-49
pubmed: 9786946
Genes (Basel). 2018 Feb 21;9(2):
pubmed: 29466320
Curr Biol. 2009 Feb 24;19(4):267-76
pubmed: 19217294
FASEB J. 2014 Nov;28(11):4729-47
pubmed: 25114175
Mol Biol Cell. 2001 Aug;12(8):2245-56
pubmed: 11514614
EMBO J. 2013 May 2;32(9):1280-92
pubmed: 23584531
J Pineal Res. 2019 Mar;66(2):e12484
pubmed: 29480948
J Cell Sci. 2008 May 1;121(Pt 9):1559-68
pubmed: 18411248
J Bioenerg Biomembr. 2008 Oct;40(5):425-33
pubmed: 18814021
PLoS Pathog. 2016 Feb 04;12(2):e1005403
pubmed: 26845335
Cell Microbiol. 2010 Mar;12(3):362-71
pubmed: 19863555
Dev Cell. 2007 Mar;12(3):363-75
pubmed: 17336903
J Cell Biol. 1998 Oct 19;143(2):351-8
pubmed: 9786947
Trends Parasitol. 2017 Mar;33(3):185-193
pubmed: 27789127
Curr Opin Microbiol. 2013 Aug;16(4):452-8
pubmed: 23927894
Eukaryot Cell. 2009 Apr;8(4):530-9
pubmed: 19218426
Cell Mol Life Sci. 2018 Feb;75(3):355-374
pubmed: 28779209
PLoS One. 2015 Jun 19;10(6):e0130356
pubmed: 26090798
J Cell Biol. 2010 Dec 13;191(6):1141-58
pubmed: 21149567
Sci Rep. 2017 Feb 16;7:42746
pubmed: 28202940
Elife. 2017 Nov 09;6:
pubmed: 29119945
Nat Methods. 2007 Dec;4(12):1003-5
pubmed: 17994029
Eukaryot Cell. 2009 Apr;8(4):520-9
pubmed: 19218423
PLoS Pathog. 2011 Dec;7(12):e1002392
pubmed: 22144892
Traffic. 2017 Mar;18(3):149-158
pubmed: 27991712
Annu Rev Microbiol. 2009;63:249-67
pubmed: 19575561
Arch Biochem Biophys. 2015 Sep 15;582:80-90
pubmed: 25731854
Nat Cell Biol. 1999 Sep;1(5):298-304
pubmed: 10559943
Nat Cell Biol. 2009 Aug;11(8):958-66
pubmed: 19578372
Science. 2002 Oct 25;298(5594):837-40
pubmed: 12399593
PLoS One. 2010 Aug 19;5(8):e12302
pubmed: 20808817
J Cell Biol. 1993 Aug;122(3):553-63
pubmed: 8101525
Nature. 2002 Aug 1;418(6897):548-52
pubmed: 12152082
Nat Struct Mol Biol. 2011 Jan;18(1):20-6
pubmed: 21170049
Science. 2013 Jan 25;339(6118):464-7
pubmed: 23349293
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Biochem Biophys Res Commun. 2018 May 15;499(3):556-562
pubmed: 29601815
Science. 2011 Oct 21;334(6054):358-62
pubmed: 21885730
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):E458-67
pubmed: 23341591
Mol Microbiol. 2019 Jan;111(1):46-64
pubmed: 30362624
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
N Engl J Med. 2007 Apr 26;356(17):1736-41
pubmed: 17460227
Cell. 2016 Sep 8;166(6):1423-1435.e12
pubmed: 27594426
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2800-5
pubmed: 25691734

Auteurs

Carmen Melatti (C)

Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom.

Manuela Pieperhoff (M)

Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom.

Leandro Lemgruber (L)

Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom.

Ehmke Pohl (E)

Department of Biosciences, & Biophysical Sciences Institute, Durham University, Durham, United Kingdom.

Lilach Sheiner (L)

Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom.

Markus Meissner (M)

Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH